This compound is a pharmaceutical intermediate containing a boronate ester group, designed for use in boronate synthesis. It features a piperidine-substituted pyridine ring structure with moderate lipophilicity and low polarity, characteristic of research intermediates used in medicinal chemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 852228-08-1
2-(4-Methylpiperazino)pyridine-5-boronic acid pinacol ester
research compound
6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester
research compound
1-(2-Tetrahydropyranyl)-1H-pyrazole-5-boronic acid pinacol ester
pharmaceutical intermediate
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
pharmaceutical intermediate
1,4-Dioxaspiro[4.5]decane-8-boronic acid pinacol ester
pharmaceutical intermediate
2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 4-methylbenzenesulfonate
pharmaceutical intermediate
2-(4-Fluorophenyl)-5-methylpyridine
pharmaceutical intermediate
1-Boc-3-hydroxypiperidine
pharmaceutical intermediate
2-piperidin-1-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MLJZIQHWAUYAPA-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCCCC3
—